CD8A and cancer: Furthermore, we observed an increase in peripheral blood CD8+ T lymphocytes and monocytes following intralymphatic injection of H101 (38.6% vs. 45.7%), with significant infiltration of CD8+ T lymphocytes in cancer nests.